Pacific Shuanglin Bio-pharmacy Co., LTD (SHE:000403)

SHE:000403 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021
Market Capitalization	15,952	15,448	19,957	16,669	20,540	18,713
Market Cap Growth	-23.55%	-22.60%	19.73%	-18.85%	9.77%	112.54%
Enterprise Value	15,181	14,283	18,990	15,725	19,928	18,927
Last Close Price	21.82	21.13	26.84	22.33	27.43	37.19
PE Ratio	22.57	20.73	32.60	28.39	52.52	100.62
Forward PE	17.33	16.77	30.96	20.90	36.40	65.37
PS Ratio	6.15	5.82	8.57	6.93	10.42	17.82
PB Ratio	1.99	1.95	2.69	2.43	3.25	19.35
P/TBV Ratio	3.07	3.02	4.34	4.11	5.85	20.80
P/FCF Ratio	-	-	66.14	114.50	250.30	120.99
P/OCF Ratio	61.87	48.01	29.39	31.80	50.32	96.04
EV/Sales Ratio	5.85	5.38	8.15	6.54	10.11	18.03
EV/EBITDA Ratio	17.26	15.63	24.64	22.32	37.04	69.09
EV/EBIT Ratio	20.07	18.01	29.97	26.79	46.32	83.53
EV/FCF Ratio	-61.75	-	62.94	108.02	242.85	122.38
Debt / Equity Ratio	0.08	0.08	0.07	0.05	0.02	0.39
Debt / EBITDA Ratio	0.74	0.71	0.64	0.52	0.26	1.39
Debt / FCF Ratio	-	-	1.64	2.57	1.72	2.46
Asset Turnover	0.29	0.30	0.28	0.32	0.45	0.71
Inventory Turnover	1.05	1.26	1.47	1.69	1.80	1.27
Quick Ratio	2.37	2.42	2.70	2.46	2.67	0.66
Current Ratio	4.19	3.74	3.72	3.18	3.85	1.35
Return on Equity (ROE)	9.16%	9.71%	8.56%	8.91%	10.73%	20.66%
Return on Assets (ROA)	5.28%	5.55%	4.77%	4.87%	6.13%	9.60%
Return on Capital (ROIC)	5.64%	6.01%	5.23%	5.35%	6.88%	12.54%
Return on Capital Employed (ROCE)	9.00%	9.60%	8.20%	8.40%	6.70%	21.90%
Earnings Yield	4.47%	4.83%	3.07%	3.52%	1.90%	0.99%
FCF Yield	-1.54%	-1.29%	1.51%	0.87%	0.40%	0.83%
Dividend Yield	2.27%	2.37%	0.74%	0.36%	0.20%	-
Payout Ratio	37.31%	35.50%	10.91%	8.46%	3.08%	96.17%
Buyback Yield / Dilution	-1.62%	-0.27%	0.31%	-3.37%	-44.24%	-0.23%
Total Shareholder Return	0.66%	2.09%	1.06%	-3.01%	-44.03%	-0.23%

Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.